These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11086653)

  • 1. Growth hormone and hypophosphatemic rickets.
    Wilson DM
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():993-8. PubMed ID: 11086653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone treatment on biochemical indices in hypophosphatemic rickets.
    Darendeliler F; Baş F; Karaaslan N; Hekim N; Bundak R; Saka N; Günöz H
    Horm Res; 2001; 55(4):191-5. PubMed ID: 11598373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F; Hokken-Koelega A
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.
    Lanes R; Harrison HE
    J Endocrinol Invest; 1990 Nov; 13(10):833-7. PubMed ID: 2096160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in X-linked hypophosphatemic rickets.
    Ariceta G; Langman CB
    Eur J Pediatr; 2007 Apr; 166(4):303-9. PubMed ID: 17171343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
    Rothenbuhler A; Esterle L; Gueorguieva I; Salles JP; Mignot B; Colle M; Linglart A
    Growth Horm IGF Res; 2017 Oct; 36():11-15. PubMed ID: 28822957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
    Davenport ML
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathic juvenile osteoporosis.
    Wright NM
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():999-1002. PubMed ID: 11086654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial hypophosphatemic rickets].
    Reusz G
    Orv Hetil; 2001 Dec; 142(48):2659-65. PubMed ID: 11778363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.
    Makitie O; Toiviainen-Salo S; Marttinen E; Kaitila I; Sochett E; Sipila I
    Horm Res; 2008; 69(4):212-20. PubMed ID: 18204268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
    Fillion M; Deal C; Van Vliet G
    J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis.
    Maison P; Chanson P
    Circulation; 2003 Nov; 108(21):2648-52. PubMed ID: 14623813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of familial hypophosphatemic rickets on dental development: a controlled, longitudinal study.
    Seow WK; Needleman HL; Holm IA
    Pediatr Dent; 1995; 17(5):346-50. PubMed ID: 8524683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
    Reiter EO
    Mol Cell Endocrinol; 2006 Jul; 254-255():221-5. PubMed ID: 16787696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets.
    Savio RM; Gosnell JE; Posen S; Reeve TS; Delbridge LW
    Arch Surg; 2004 Feb; 139(2):218-22. PubMed ID: 14769584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of idiopathic short stature: clinical studies.
    Hintz RL
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S6-8. PubMed ID: 16039887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.